Literature DB >> 18750025

Neurosurgery: chemotherapy in conjunction with blood-brain barrier modification in patients with cerebral metastasis.

E A Neuwelt, S A Hill.   

Abstract

Entities:  

Year:  1986        PMID： 18750025      PMCID： PMC1306825     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  2 in total

1.  Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.

Authors:  E A Neuwelt; E P Frenkel; J Diehl; L H Vu; S Rapoport; S Hill
Journal:  Neurosurgery       Date:  1980-07       Impact factor: 4.654

2.  Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.

Authors:  E A Neuwelt; S A Hill; E P Frenkel
Journal:  Neurosurgery       Date:  1984-09       Impact factor: 4.654
  2 in total
  1 in total

1.  Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.

Authors:  John A Boockvar; Apostolos J Tsiouris; Christoph P Hofstetter; Ilhami Kovanlikaya; Sherese Fralin; Kartik Kesavabhotla; Stephen M Seedial; Susan C Pannullo; Theodore H Schwartz; Philip Stieg; Robert D Zimmerman; Jared Knopman; Ronald J Scheff; Paul Christos; Shankar Vallabhajosula; Howard A Riina
Journal:  J Neurosurg       Date:  2010-10-22       Impact factor: 5.115
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.